LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article: Fibroblast‐mediated intercellular crosstalk in the healthy and diseased heart

    Nicin, Luka / Wagner, Julian U. G. / Luxán, Guillermo / Dimmeler, Stefanie

    FEBS letters. 2022 Mar., v. 596, no. 5

    2022  

    Abstract: Cardiac fibroblasts constitute a major cell population in the heart. They secrete extracellular matrix components and various other factors shaping the microenvironment of the heart. In silico analysis of intercellular communication based on single‐cell ... ...

    Abstract Cardiac fibroblasts constitute a major cell population in the heart. They secrete extracellular matrix components and various other factors shaping the microenvironment of the heart. In silico analysis of intercellular communication based on single‐cell RNA sequencing revealed that fibroblasts are the source of the majority of outgoing signals to other cell types. This observation suggests that fibroblasts play key roles in orchestrating cellular interactions that maintain organ homeostasis but that can also contribute to disease states. Here, we will review the current knowledge of fibroblast interactions in the healthy, diseased, and aging heart. We focus on the interactions that fibroblasts establish with other cells of the heart, specifically cardiomyocytes, endothelial cells and immune cells, and particularly those relying on paracrine, electrical, and exosomal communication modes.
    Keywords RNA ; cardiomyocytes ; cell communication ; computer simulation ; extracellular matrix ; fibroblasts ; homeostasis
    Language English
    Dates of publication 2022-03
    Size p. 638-654.
    Publishing place John Wiley & Sons, Ltd
    Document type Article
    Note REVIEW
    ZDB-ID 212746-5
    ISSN 1873-3468 ; 0014-5793
    ISSN (online) 1873-3468
    ISSN 0014-5793
    DOI 10.1002/1873-3468.14234
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: Fibroblast-mediated intercellular crosstalk in the healthy and diseased heart.

    Nicin, Luka / Wagner, Julian U G / Luxán, Guillermo / Dimmeler, Stefanie

    FEBS letters

    2021  Volume 596, Issue 5, Page(s) 638–654

    Abstract: Cardiac fibroblasts constitute a major cell population in the heart. They secrete extracellular matrix components and various other factors shaping the microenvironment of the heart. In silico analysis of intercellular communication based on single-cell ... ...

    Abstract Cardiac fibroblasts constitute a major cell population in the heart. They secrete extracellular matrix components and various other factors shaping the microenvironment of the heart. In silico analysis of intercellular communication based on single-cell RNA sequencing revealed that fibroblasts are the source of the majority of outgoing signals to other cell types. This observation suggests that fibroblasts play key roles in orchestrating cellular interactions that maintain organ homeostasis but that can also contribute to disease states. Here, we will review the current knowledge of fibroblast interactions in the healthy, diseased, and aging heart. We focus on the interactions that fibroblasts establish with other cells of the heart, specifically cardiomyocytes, endothelial cells and immune cells, and particularly those relying on paracrine, electrical, and exosomal communication modes.
    MeSH term(s) Cell Communication ; Endothelial Cells ; Fibroblasts/metabolism ; Myocytes, Cardiac/metabolism
    Language English
    Publishing date 2021-12-01
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 212746-5
    ISSN 1873-3468 ; 0014-5793
    ISSN (online) 1873-3468
    ISSN 0014-5793
    DOI 10.1002/1873-3468.14234
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cardiomyocyte hyperplasia and immaturity but not hypertrophy are characteristic features of patients with RASopathies.

    Drenckhahn, Jörg-Detlef / Nicin, Luka / Akhouaji, Sara / Krück, Svenja / Blank, Anna Eva / Schänzer, Anne / Yörüker, Uygar / Jux, Christian / Tombor, Lukas / Abplanalp, Wesley / John, David / Zeiher, Andreas M / Dimmeler, Stefanie / Rupp, Stefan

    Journal of molecular and cellular cardiology

    2023  Volume 178, Page(s) 22–35

    Abstract: Aims: RASopathies are caused by mutations in genes that alter the MAP kinase pathway and are marked by several malformations with cardiovascular disorders as the predominant cause of mortality. Mechanistic insights in the underlying pathogenesis in ... ...

    Abstract Aims: RASopathies are caused by mutations in genes that alter the MAP kinase pathway and are marked by several malformations with cardiovascular disorders as the predominant cause of mortality. Mechanistic insights in the underlying pathogenesis in affected cardiac tissue are rare. The aim of the study was to assess the impact of RASopathy causing mutations on the human heart.
    Methods and results: Using single cell approaches and histopathology we analyzed cardiac tissue from children with different RASopathy-associated mutations compared to age-matched dilated cardiomyopathy (DCM) and control hearts. The volume of cardiomyocytes was reduced in RASopathy conditions compared to controls and DCM patients, and the estimated number of cardiomyocytes per heart was ∼4-10 times higher. Single nuclei RNA sequencing of a 13-year-old RASopathy patient (carrying a PTPN11 c.1528C > G mutation) revealed that myocardial cell composition and transcriptional patterns were similar to <1 year old DCM hearts. Additionally, immaturity of cardiomyocytes is shown by an increased MYH6/MYH7 expression ratio and reduced expression of genes associated with fatty acid metabolism. In the patient with the PTPN11 mutation activation of the MAP kinase pathway was not evident in cardiomyocytes, whereas increased phosphorylation of PDK1 and its downstream kinase Akt was detected.
    Conclusion: In conclusion, an immature cardiomyocyte differentiation status appears to be preserved in juvenile RASopathy patients. The increased mass of the heart in such patients is due to an increase in cardiomyocyte number (hyperplasia) but not an enlargement of individual cardiomyocytes (hypertrophy).
    MeSH term(s) Child ; Infant ; Humans ; Adolescent ; Myocytes, Cardiac/metabolism ; Hyperplasia/metabolism ; Mutation ; Mitogen-Activated Protein Kinases/metabolism ; Hypertrophy/metabolism ; Cardiomyopathy, Dilated/genetics ; Cardiomyopathy, Dilated/metabolism
    Chemical Substances Mitogen-Activated Protein Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2023-03-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80157-4
    ISSN 1095-8584 ; 0022-2828
    ISSN (online) 1095-8584
    ISSN 0022-2828
    DOI 10.1016/j.yjmcc.2023.03.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease.

    Kattih, Badder / Boeckling, Felicitas / Shumliakivska, Mariana / Tombor, Lukas / Rasper, Tina / Schmitz, Katja / Hoffmann, Jedrzej / Nicin, Luka / Abplanalp, Wesley T / Carstens, Daniel C / Arsalan, Mani / Emrich, Fabian / Holubec, Tomas / Walther, Thomas / Puntmann, Valentina O / Nagel, Eike / John, David / Zeiher, Andreas M / Dimmeler, Stefanie

    Cardiovascular research

    2023  Volume 119, Issue 15, Page(s) 2550–2562

    Abstract: Aims: Cardiac fibrosis drives the progression of heart failure in ischaemic and hypertrophic cardiomyopathy. Therefore, the development of specific anti-fibrotic treatment regimens to counteract cardiac fibrosis is of high clinical relevance. Hence, ... ...

    Abstract Aims: Cardiac fibrosis drives the progression of heart failure in ischaemic and hypertrophic cardiomyopathy. Therefore, the development of specific anti-fibrotic treatment regimens to counteract cardiac fibrosis is of high clinical relevance. Hence, this study examined the presence of persistent fibroblast activation during longstanding human heart disease at a single-cell resolution to identify putative therapeutic targets to counteract pathological cardiac fibrosis in patients.
    Methods and results: We used single-nuclei RNA sequencing with human tissues from two samples of one healthy donor, and five hypertrophic and two failing hearts. Unsupervised sub-clustering of 7110 nuclei led to the identification of 7 distinct fibroblast clusters. De-convolution of cardiac fibroblast heterogeneity revealed a distinct population of human cardiac fibroblasts with a molecular signature of persistent fibroblast activation and a transcriptional switch towards a pro-fibrotic extra-cellular matrix composition in patients with established cardiac hypertrophy and heart failure. This sub-cluster was characterized by high expression of POSTN, RUNX1, CILP, and a target gene adipocyte enhancer-binding protein 1 (AEBP1) (all P < 0.001). Strikingly, elevated circulating AEBP1 blood level were also detected in a validation cohort of patients with confirmed cardiac fibrosis and hypertrophic cardiomyopathy by cardiac magnetic resonance imaging (P < 0.01). Since endogenous AEBP1 expression was increased in patients with established cardiac hypertrophy and heart failure, we assessed the functional consequence of siRNA-mediated AEBP1 silencing in human cardiac fibroblasts. Indeed, AEBP1 silencing reduced proliferation, migration, and fibroblast contractile capacity and α-SMA gene expression, which is a hallmark of fibroblast activation (all P < 0.05). Mechanistically, the anti-fibrotic effects of AEBP1 silencing were linked to transforming growth factor-beta pathway modulation.
    Conclusion: Together, this study identifies persistent fibroblast activation in patients with longstanding heart disease, which might be detected by circulating AEBP1 and therapeutically modulated by its targeted silencing in human cardiac fibroblasts.
    MeSH term(s) Humans ; Heart Failure/metabolism ; Heart Diseases/pathology ; Cardiomegaly/metabolism ; Cardiomyopathy, Hypertrophic/metabolism ; Cardiomyopathies/metabolism ; Fibrosis ; Fibroblasts/metabolism ; Gene Expression Profiling ; Carboxypeptidases/metabolism ; Repressor Proteins/metabolism
    Chemical Substances AEBP1 protein, human ; Carboxypeptidases (EC 3.4.-) ; Repressor Proteins
    Language English
    Publishing date 2023-08-30
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80340-6
    ISSN 1755-3245 ; 0008-6363
    ISSN (online) 1755-3245
    ISSN 0008-6363
    DOI 10.1093/cvr/cvad140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Endothelial cells drive organ fibrosis in mice by inducing expression of the transcription factor SOX9.

    Trogisch, Felix A / Abouissa, Aya / Keles, Merve / Birke, Anne / Fuhrmann, Manuela / Dittrich, Gesine M / Weinzierl, Nina / Wink, Elvira / Cordero, Julio / Elsherbiny, Adel / Martin-Garrido, Abel / Grein, Steve / Hemanna, Shruthi / Hofmann, Ellen / Nicin, Luka / Bibli, Sofia-Iris / Airik, Rannar / Kispert, Andreas / Kist, Ralf /
    Quanchao, Sun / Kürschner, Sina W / Winkler, Manuel / Gretz, Norbert / Mogler, Carolin / Korff, Thomas / Koch, Philipp-Sebastian / Dimmeler, Stefanie / Dobreva, Gergana / Heineke, Joerg

    Science translational medicine

    2024  Volume 16, Issue 736, Page(s) eabq4581

    Abstract: Fibrosis is a hallmark of chronic disease. Although fibroblasts are involved, it is unclear to what extent endothelial cells also might contribute. We detected increased expression of the transcription ... ...

    Abstract Fibrosis is a hallmark of chronic disease. Although fibroblasts are involved, it is unclear to what extent endothelial cells also might contribute. We detected increased expression of the transcription factor
    MeSH term(s) Animals ; Humans ; Mice ; Disease Models, Animal ; Endothelial Cells ; Fibrosis ; Heart Failure ; Intercellular Signaling Peptides and Proteins ; Liver Cirrhosis/complications ; SOX9 Transcription Factor/genetics ; Transcription Factors
    Chemical Substances Intercellular Signaling Peptides and Proteins ; SOX9 protein, human ; SOX9 Transcription Factor ; Transcription Factors ; Sox9 protein, mouse
    Language English
    Publishing date 2024-02-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.abq4581
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts.

    Nicin, Luka / Abplanalp, Wesley Tyler / Mellentin, Hannah / Kattih, Badder / Tombor, Lukas / John, David / Schmitto, Jan D / Heineke, Jörg / Emrich, Fabian / Arsalan, Mani / Holubec, Tomas / Walther, Thomas / Zeiher, Andreas M / Dimmeler, Stefanie

    European heart journal

    2020  Volume 41, Issue 19, Page(s) 1804–1806

    MeSH term(s) Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme 2 ; Betacoronavirus ; COVID-19 ; Case-Control Studies ; Cell Nucleus/genetics ; Coronavirus Infections ; Female ; Gene Expression ; Humans ; Male ; Middle Aged ; Myocardium/cytology ; Myocytes, Cardiac/metabolism ; Pandemics ; Peptidyl-Dipeptidase A/genetics ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral ; SARS-CoV-2 ; Sequence Analysis, RNA
    Chemical Substances ACE protein, human (EC 3.4.15.1) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Keywords covid19
    Language English
    Publishing date 2020-04-15
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehaa311
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: An In Vitro Model for Identifying Cardiac Side Effects of Anesthetics.

    Chang, Alex C Y / Chang, Andrew C H / Nicin, Luka / Weber, Gerhard J / Holbrook, Colin / Davies, M Frances / Blau, Helen M / Bertaccini, Edward J

    Anesthesia and analgesia

    2018  Volume 130, Issue 1, Page(s) e1–e4

    Abstract: The understanding of anesthetic side effects on the heart has been hindered by the lack of sophisticated clinical models. Using micropatterned human-induced pluripotent stem cell-derived cardiomyocytes, we obtained cardiac muscle depressant profiles for ... ...

    Abstract The understanding of anesthetic side effects on the heart has been hindered by the lack of sophisticated clinical models. Using micropatterned human-induced pluripotent stem cell-derived cardiomyocytes, we obtained cardiac muscle depressant profiles for propofol, etomidate, and our newly identified anesthetic compound KSEB01-S2. Propofol was the strongest depressant among the 3 compounds tested, exhibiting the largest decrease in contraction velocity, depression rate, and beating frequency. Interestingly, KSEB01-S2 behaved similarly to etomidate, suggesting a better cardiac safety profile. Our results provide a proof-of-concept for using human-induced pluripotent stem cell-derived cardiomyocytes as an in vitro platform for future drug design.
    MeSH term(s) Adult ; Anesthetics, Intravenous/toxicity ; Cardiotoxicity ; Cell Line ; Etomidate/toxicity ; Female ; Heart Diseases/chemically induced ; Heart Diseases/pathology ; Heart Diseases/physiopathology ; Heart Rate/drug effects ; Humans ; Induced Pluripotent Stem Cells/drug effects ; Induced Pluripotent Stem Cells/pathology ; Male ; Middle Aged ; Myocardial Contraction/drug effects ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/pathology ; Proof of Concept Study ; Propofol/toxicity ; Risk Assessment ; Time Factors ; Young Adult
    Chemical Substances Anesthetics, Intravenous ; Propofol (YI7VU623SF) ; Etomidate (Z22628B598)
    Language English
    Publishing date 2018-08-31
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Video-Audio Media
    ZDB-ID 80032-6
    ISSN 1526-7598 ; 0003-2999
    ISSN (online) 1526-7598
    ISSN 0003-2999
    DOI 10.1213/ANE.0000000000003757
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy.

    Nicin, Luka / Abplanalp, Wesley T / Schänzer, Anne / Sprengel, Anke / John, David / Mellentin, Hannah / Tombor, Lukas / Keuper, Matthias / Ullrich, Evelyn / Klingel, Karin / Dettmeyer, Reinhard B / Hoffmann, Jedrzej / Akintuerk, Hakan / Jux, Christian / Schranz, Dietmar / Zeiher, Andreas M / Rupp, Stefan / Dimmeler, Stefanie

    Circulation

    2021  Volume 143, Issue 17, Page(s) 1704–1719

    Abstract: Background: Dilated cardiomyopathy (DCM) is a leading cause of death in children with heart failure. The outcome of pediatric heart failure treatment is inconsistent, and large cohort studies are lacking. Progress may be achieved through personalized ... ...

    Abstract Background: Dilated cardiomyopathy (DCM) is a leading cause of death in children with heart failure. The outcome of pediatric heart failure treatment is inconsistent, and large cohort studies are lacking. Progress may be achieved through personalized therapy that takes age- and disease-related pathophysiology, pathology, and molecular fingerprints into account. We present single nuclei RNA sequencing from pediatric patients with DCM as the next step in identifying cellular signatures.
    Methods: We performed single nuclei RNA sequencing with heart tissues from 6 children with DCM with an age of 0.5, 0.75, 5, 6, 12, and 13 years. Unsupervised clustering of 18 211 nuclei led to the identification of 14 distinct clusters with 6 major cell types.
    Results: The number of nuclei in fibroblast clusters increased with age in patients with DCM, a finding that was confirmed by histological analysis and was consistent with an age-related increase in cardiac fibrosis quantified by cardiac magnetic resonance imaging. Fibroblasts of patients with DCM >6 years of age showed a profoundly altered gene expression pattern with enrichment of genes encoding fibrillary collagens, modulation of proteoglycans, switch in thrombospondin isoforms, and signatures of fibroblast activation. In addition, a population of cardiomyocytes with a high proregenerative profile was identified in infant patients with DCM but was absent in children >6 years of age. This cluster showed high expression of cell cycle activators such as
    Conclusions: Novel insights into the cellular transcriptomes of hearts from pediatric patients with DCM provide remarkable age-dependent changes in the expression patterns of fibroblast and cardiomyocyte genes with less fibrotic but enriched proregenerative signatures in infants.
    MeSH term(s) Cardiomyopathy, Dilated/genetics ; Cardiomyopathy, Dilated/pathology ; Cell Proliferation ; Child ; Child, Preschool ; Female ; High-Throughput Nucleotide Sequencing/methods ; Humans ; Male ; Sequence Analysis, RNA/methods
    Language English
    Publishing date 2021-02-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.120.051391
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release.

    Wagner, Nils / Dieteren, Scott / Franz, Niklas / Köhler, Kernt / Mörs, Katharina / Nicin, Luka / Schmidt, Julia / Perl, Mario / Marzi, Ingo / Relja, Borna

    PloS one

    2018  Volume 13, Issue 2, Page(s) e0192171

    Abstract: Background: The treatment of patients with multiple trauma including blunt chest/thoracic trauma (TxT) and hemorrhagic shock (H) is still challenging. Numerous studies show detrimental consequences of TxT and HS resulting in strong inflammatory changes, ...

    Abstract Background: The treatment of patients with multiple trauma including blunt chest/thoracic trauma (TxT) and hemorrhagic shock (H) is still challenging. Numerous studies show detrimental consequences of TxT and HS resulting in strong inflammatory changes, organ injury and mortality. Additionally, the reperfusion (R) phase plays a key role in triggering inflammation and worsening outcome. Ethyl pyruvate (EP), a stable lipophilic ester, has anti-inflammatory properties. Here, the influence of EP on the inflammatory reaction and liver injury in a double hit model of TxT and H/R in rats was explored.
    Methods: Female Lewis rats were subjected to TxT followed by hemorrhage/H (60 min, 35±3 mm Hg) and resuscitation/R (TxT+H/R). Reperfusion was performed by either Ringer`s lactated solution (RL) alone or RL supplemented with EP (50 mg/kg). Sham animals underwent all surgical procedures without TxT+H/R. After 2h, blood and liver tissue were collected for analyses, and survival was assessed after 24h.
    Results: Resuscitation with EP significantly improved haemoglobin levels and base excess recovery compared with controls after TxT+H/R, respectively (p<0.05). TxT+H/R-induced significant increase in alanine aminotransferase levels and liver injury were attenuated by EP compared with controls (p<0.05). Local inflammation as shown by increased gene expression of IL-6 and ICAM-1, enhanced ICAM-1 and HMGB1 protein expression and infiltration of the liver with neutrophils were also significantly attenuated by EP compared with controls after TxT+H/R (p<0.05). EP significantly reduced TxT+H/R-induced p65 activation in liver tissue. Survival rates improved by EP from 50% to 70% after TxT+H/R.
    Conclusions: These data support the concept that the pronounced local pro-inflammatory response in the liver after blunt chest trauma and hemorrhagic shock is associated with NF-κB. In particular, the beneficial anti-inflammatory effects of ethyl pyruvate seem to be regulated by the HMGB1/NF-κB axis in the liver, thereby, restraining inflammatory responses and liver injury after double hit trauma in the rat.
    MeSH term(s) Animals ; Female ; HMGB1 Protein/metabolism ; Inflammation/prevention & control ; Liver/drug effects ; Liver/injuries ; NF-kappa B/metabolism ; Pyruvates/pharmacology ; Rats ; Rats, Inbred Lew ; Shock, Hemorrhagic/complications ; Thoracic Injuries/complications ; Wounds, Nonpenetrating/complications
    Chemical Substances HMGB1 Protein ; Hbp1 protein, rat ; NF-kappa B ; Pyruvates ; ethyl pyruvate (03O98E01OB)
    Language English
    Publishing date 2018
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0192171
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants.

    Wagner, Julian U G / Bojkova, Denisa / Shumliakivska, Mariana / Luxán, Guillermo / Nicin, Luka / Aslan, Galip S / Milting, Hendrik / Kandler, Joshua D / Dendorfer, Andreas / Heumueller, Andreas W / Fleming, Ingrid / Bibli, Sofia-Iris / Jakobi, Tobias / Dieterich, Christoph / Zeiher, Andreas M / Ciesek, Sandra / Cinatl, Jindrich / Dimmeler, Stefanie

    Basic research in cardiology

    2021  Volume 116, Issue 1, Page(s) 42

    Abstract: Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It ... ...

    Abstract Coronavirus disease 2019 (COVID-19) spawned a global health crisis in late 2019 and is caused by the novel coronavirus SARS-CoV-2. SARS-CoV-2 infection can lead to elevated markers of endothelial dysfunction associated with higher risk of mortality. It is unclear whether endothelial dysfunction is caused by direct infection of endothelial cells or is mainly secondary to inflammation. Here, we investigate whether different types of endothelial cells are susceptible to SARS-CoV-2. Human endothelial cells from different vascular beds including umbilical vein endothelial cells, coronary artery endothelial cells (HCAEC), cardiac and lung microvascular endothelial cells, or pulmonary arterial cells were inoculated in vitro with SARS-CoV-2. Viral spike protein was only detected in HCAECs after SARS-CoV-2 infection but not in the other endothelial cells tested. Consistently, only HCAEC expressed the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2), required for virus infection. Infection with the SARS-CoV-2 variants B.1.1.7, B.1.351, and P.2 resulted in significantly higher levels of viral spike protein. Despite this, no intracellular double-stranded viral RNA was detected and the supernatant did not contain infectious virus. Analysis of the cellular distribution of the spike protein revealed that it co-localized with endosomal calnexin. SARS-CoV-2 infection did induce the ER stress gene EDEM1, which is responsible for clearance of misfolded proteins from the ER. Whereas the wild type of SARS-CoV-2 did not induce cytotoxic or pro-inflammatory effects, the variant B.1.1.7 reduced the HCAEC cell number. Of the different tested endothelial cells, HCAECs showed highest viral uptake but did not promote virus replication. Effects on cell number were only observed after infection with the variant B.1.1.7, suggesting that endothelial protection may be particularly important in patients infected with this variant.
    MeSH term(s) Angiotensin-Converting Enzyme 2/metabolism ; Calnexin/metabolism ; Cells, Cultured ; Endoplasmic Reticulum/metabolism ; Endoplasmic Reticulum/virology ; Endoplasmic Reticulum Stress ; Endothelial Cells/metabolism ; Endothelial Cells/virology ; Host-Pathogen Interactions ; Humans ; Membrane Proteins/metabolism ; Receptors, Virus/metabolism ; SARS-CoV-2/genetics ; SARS-CoV-2/metabolism ; SARS-CoV-2/pathogenicity ; Spike Glycoprotein, Coronavirus/metabolism
    Chemical Substances CANX protein, human ; EDEM1 protein, human ; Membrane Proteins ; Receptors, Virus ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 ; Calnexin (139873-08-8) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Language English
    Publishing date 2021-07-05
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 189755-x
    ISSN 1435-1803 ; 0300-8428 ; 0175-9418
    ISSN (online) 1435-1803
    ISSN 0300-8428 ; 0175-9418
    DOI 10.1007/s00395-021-00882-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top